Bologna 13-05-2021
Matteo Ravaioli
Telefono
+39.0512144810 (ufficio);
+39.0512144785 (segreteria per appuntamenti e attività libero professionale)
link:
https://www.topdoctors.it/dottor/matteo-ravaioli;
https://tumoritrapiantisecondopinion.it
https://www.youtube.com/watch?v=2ou1-AO67C4
E-mail
matteo.ravaioli6@unibo.it; mrava1@hotmail.com; matteo.ravaioli@aosp.bo.it;
Nazionalità: Italiana
Data di nascita: 11-10-1974
Esperienze professionali
2010-ad oggi: Dirigente Medico di Chirurgia Generale presso l'UO Chirurgia Generale e dei Trapianti dell'AOU di Bologna Pol. S. Orsola Malpighi. Interesse clinico: chirurgia dei pazienti affetti da HCC, metastasi epatiche, tumori bilio-pancreatici e trapianti di fegato, di rene e multiorgano (Chirurgia, terapia immunosoppressiva, gestione post-operatoria e follow-up).
Dal 2015 è Responsabile chirurgico del programma di attività del trapianto di rene.
Da settembre-2020 è responsabile del programma di Chirurgia Addominale dei pazienti con insuf. d'organo e trapiantati.
Ha eseguito più di 2550 interventi chirurgici, tra i più frequenti resezioni epatiche minori, maggiori e laparoscopiche (534), trapianto di fegato (260), trapianto di rene da cadavere e da vivente (483), nefrectomia per neoplasia o a scopo di donazione (262); gli altri interventi eseguiti includono prelievo di organi includendo “split-liver”, interventi di chirurgia generale come appendicectomia laparoscopica, colecistectomia laparoscopica, chirurgia colo-rettale, resezioni gastriche e pancreatiche.
2008-2009 Chirurgo con contratto a tempo det. presso l'UO Chirurgia Generale e dei Trapianti AOU di Bologna Pol. S. Orsola Malpighi – Dir. Prof. A. D. Pinna.
2009-2010 Chirurgo con contratto a tempo indet. presso l'UO Chirurgia Generale e di Urgenza dell'Ospedale Infermi di Rimini - Dir. Dr. G. Francioni.
2000-2005 Medico-chirurgo specialista in Chirurgia Generale Libero Professionista presso U.O. Chirurgia dei Trapianti di fegato e multiorgano dell'AOU di Bologna Pol. S. Orsola Malpighi - Dir. Prof. A. D. Pinna.
Formazione ed educazione
Luglio-Agosto 1996: “Visiting Faculty” presso il Dipartimento di Chirurgia Vascolare dell'Università McMaster ad Hamilton (Canada) - Direttore Prof. Claudio Cina.
Luglio-Agosto 1998: “Visiting Faculty” presso il Dipartimento di Chirurgia Gastrointestinale dell'Instituto “Imperial College of Science, Technology and Medicine” a London - Direttore Prof. R.C.N. Williamson.
1999: Laurea in Medicina e Chirurgia – Università degli Studi di Bologna
2000: Abilitazione all'esercizio della libera professione di Medico ed iscrizione all'Ordine dei Medici di Bologna.
Luglio-Agosto 2002: “Visiting Faculty” presso il Dipartimento di “Liver Transplantation” del King's College Hospital di Londra - Direttore Prof. Nigel Heaton.
Luglio-Agosto 2003: “Visiting Faculty” presso il Dipartimento di Chirurgia Epatobiliare dell'ospedale Beaujon di Paris - Direttore Prof. Jack Belghiti.
2003: Corso Il Trapianto di Fegato per Epatocarcinoma in Cirrosi, Bologna – Prof. Luigi Frati
2005: Specializzazione in Chirurgia Generale presso l'UO Chirurgia Generale e dei Trapianti AOU di Bologna Pol. S. Orsola Malpighi – Dir. Prof. A. Cavallari e dal 2005 Prof. A.D. Pinna.
2005-2008: Dottorato di ricerca in Scienze medico-chirurgiche gastroenterologiche presso l'Università degli Studi di Bologna.
2006: “Visiting Faculty” presso il Dipartimento di Chirurgia Epatobiliare al Asan Medical Center di Seoul – Direttore: Prof. Sung-Gyu Lee completando la formazione su: chirurgia epatobiliare e trapianto di fegato da donatore vivente.
2006: Premio F. Mazzeo per il miglior lavoro scientifico presentato al XXIII congresso nazionale S.I.P.A.D.
2008: corso teorico pratico in chirurgia resettiva laparoscopica multi viscerale, facoltà agraria di San Pietro, Perugia – Presidente Filippo Calzolati
2009: Corso di Chirurgia Epatobiliare sulla procedura “split liver transplantation” in Ghent, Belgium – Direttore: Prof. Troisi.
2013: CRSA European Chapter HPB Course, ACOI’s Special School of Mini Invasive Robotic Surgery of Misericordia Hospital, Grosseto.
2013: Advanced Laparoscopic Course for Solid Organ Surgery, AIMS Accademy in Milan – Prof. Raffaele Pugliese.
2014: Corso teorico pratico di prelievo di rene laparoscopico per trapianto di rene da donatore vivente, Fondazione S.S.P., Padova – Direttore Giovanni Guglielmi.
2014: Corso avanzato di nefrectomia robotica a scopo di trapianto, Ospedale Niguarda, Milano.
2015: Corso avanzato di Chirurgia laparospcopica mini-invasiva, Nuovo Ospedale Civile Sant’Agostino-Estense di Modena – Direttore: Prof. Gianluigi Melotti.
2016: III Corso Avanzato di Nefrectomia Robotica a scopo di Trapianto, Milano ASST Grande Ospedale Metropolitano Niguarda.
2019: Corso di Chirurgia generale epatobiliare dell’ospedale San Raffaele di Milano; Scuola italiana di chirurgia mini invasiva del fegato, I Go MILS – Coordinatore: Dott. Luca Aldrighetti.
Attività di ricerca
H-index 48 – Scopus
Autore e co-autore di più di 220 pubblicazioni scientifiche con 5859citazioni ottenute da 4873 documenti.
Idoneità Nazionale Professore seconda fascia in Chirurgia Generale nel 2013.
Idoneità Nazionale Professore prima fascia in Chirurgia Generale nel 2017.
Interessi di ricerca: la perfusione degli organi, il trapianto di fegato, il trapianto di rene, la gestione della terapia immunosoppressiva nei pazienti trapiantati di fegato, la resezione epatica, la classificazione molecolare dell'epatocarcinoma.
Progetti di ricerca:
Hepatic preconditioning: molecular mechanisms responsible for the induction of tolerance to ischemia-reperfusion and clinical applications in liver resection and transplantation. PRIN 2004; Componente del gruppo di ricerca.
Immunological, virological and oncological follow-up of the liver recipients. Programma di ricerca Regione-Università 2007-2009; Componente del gruppo di ricerca.
Molecular classification of hepatocellular carcinoma to select the more appropriate surgical treatment: liver transplantation or liver resection. Programma di ricerca Regione-Università 2010-2012 - Bando Giovani Ricercatori; Sperimentatore principale.
Strategie innovative per la conservazione degli organi pre-trapianto: sviluppo di una macchina per la perfusione in condizioni di ipotermia, normotermia e ossigenazione normo ed iperbarica. Fondo per la Modernizzazione 2010-2011-2012; Sperimentatore principale.
Comparazione tra perfusione ossigenata ipotermica e conservazione ipotermica standard per gli organi provenienti da donatore marginale. Studio con dispositivo medico. Contributo - Fondazione del Monte, 2015; Componente del gruppo di ricerca.
L'uso dei liquidi di perfusione per la preservazione del graft. Studio osservazionale; Sperimentatore principale.
Strategie di rigenerazione e di ricondizionamento degli organi marginali, fegato e rene, a scopo di trapianto. Studio interventistico senza medicinali. Contributo: ricerca finalizzata, 2016; Sperimentatore principale.
Madre lingua
Italiano
Altre lingue
English
• Lettura
Buono
• Scrittura
Buono
• Espressione orale
Buono
Ulteriori Informazioni
Relatore su invito e/o di studi scientifici presso i seguenti Convegni/Congressi Internazionali:
-XI International Transplant Symposium, Madrid 2018;
- 21st Annual Meeting of the European Surgical Association, Atene 2014;
- European Surgical Association, Edimburgo 2013;
-10th World Congress of the International Hepato-Pancreato-Biliary Association; Paris 2012;
-18th International Liver Transplant Society; San Francisco 2012;
-1st European Meeting of Young Surgeons; Rome 2009;
-20th Japanese society of small bowel transplantation; Osaka 2008.
Relatore su invito e/o di studi scientifici presso i seguenti Convegni/Congressi Nazionali:
- Spring Meeting della società italiana dei trapianti d’organo e di tessuti, Rimini 2019;
- Progetto SIN Winter Spring School on Kidney Transplantation, Bologna 2019;
- 1st G.I.Co MEETING Intrahepatic cholangiocarcinoma, Bologna 2019;
- Presentazione e diffusione dei dati relativi allo studio clinico PIO-700: la perfusione ipotermica ossigenata negli organi marginali, Bologna 2018;
- II Edizione I Bookmarks in Ecografia, Bologna, 2018;
-59° Congresso Nazionale, l’arte della cura tra sapere scientifico e visione antropologica, Rimini 2018;
- Multidisciplinarietà nei NET: chimera o realtà?, Imola 2018;
- Congresso congiunto della società scientifiche italiane di chirurgia, Roma 2018;
- Common grounds in pharmacological and therapeutic advances. The millennium drugs. Bilancio ragionato del reale impatto dei nuovi trattamenti in ambito nefrologico, Bologna 2018;
- SISOT, società italiana per la sicurezza e la qualità nei trapianti, Firenze 2018;
- 43RD Annual Scientific Meeting, Ravenna 2017;
-41° T.P.M.-Transplant Procurement Management, Roma 2017;
-Course in surgery of liver and biliary diseases, Bologna 2017;
-Bologna forum meeting in liver surgery and transplantation, Bologna 2017;
-58° Congresso Nazionale, Società Italiana di Nefrologia, Rimini 2017;
-XIII corso d’aggiornamento in chirurgia del trapianto del fegato, Bologna 2017;
-I trapianti d’organo e la ricerca scientifica: le nuove frontiere, Bologna 2017;
- Il trapianto di rene: prima e dopo, Bologna 2016;
-Percorso diagnostico-terapeutico della malattia metastatica epatica da adenocarcinoma del colon, Bologna 2016;
- Il trapianto renale da vivente tra sogno e realtà, Ferrara 2016;
- Focus on organ perfusion for clinical transplantation, Milano 2016;
- Donor Actions and Organ Procurements, Bologna 2016;
- Grandangolo in Nefrologia, Dialisi e Trapianto, Bologna 2016;
- Le complicanze nei trapianti di organo solido, Bologna 2015;
- Grandangolo 2015 nel trapianto di Organi Solidi, Bologna 2015;
- Il trapianto di rene e il trapianto di fegato da donatore vivente in Italia: da favolosa prospettiva a difficile realtà, Bologna 2015;
- XXV Convegno AIRT, Torino 2014;
- La Clinica e l'Industria Medicale a confronto nei Trapianti di Organo Solido, Bologna 2014;
- Metastasi epatiche da tumori del colon-retto: strategie terapeutiche, Rimini 2014;
- Grandangolo 2014 nel trapianto di Organi Solidi & Interdisciplinary Seminar in Nephrology and Organ Replacement. Le gravi insufficienze d'Organo ed il loro trattamento sostitutivo artificiale, Bologna 2014;
- NET Stage, Bologna 2013;
- Il trapianto di rene da vivente a Bologna: aspetti clinici e organizzativi, Rimini 2013;
- Highlights in Hepatology, Faenza 2013;
- La gestione clinica del paziente con trapianto di fegato: le complicanze long-term, Bologna 2013;
- Novità e prospettive nel controllo delle infezioni del paziente trapiantato d'organo solido AMCLI, Bologna 2013;
- Surgical Hot Topics, Symposium, Rome 2012;
-XXXVI Congresso Nazionale S.I.T.O., Torino 2012;
-23° Convegno AIRT, Montecatini 2012;
-7° Congresso del capitolo italiano IT-IHPBA, Bologna 2012;
-Aggiornamenti in tema di trapianto d'organo, Bologna 2011;
-Carcinoma del colon-retto, Rimini 2011;
-Il trapianto di rene con NHBD, Bologna 2011;
-XXX congresso nazionale ACOI, Ascoli Piceno 2011
-Corso base di Chirurgia Laparoscopica, Modena 2010;
- 1st European Meeting of young surgeons, Roma 2009;
-Grandangolo 2009 in Chirurgia Generale, Bologna 2009;
-La radiologia sotto i portici, Bologna 2009;
- Il prelievo multi organo, Padova 2008;
-Grandangolo 2008 in Chirurgia Generale, Bologna 2008;
-31° Congresso S.I.T.O., Modena 2007;
-XXIII congresso nazionale della S.I.P.A.D., Alghero 2006;
-2° corso integrato di stadiazione e trattamento delle metastasi epatiche, San Leo 2005.
Revisore delle seguenti riviste scientifiche:
-Liver Transplantation;
-Clinical Transplantation;
-Digestive and Liver Disease;
-Journal of Hepatology;
-Expert Review of Anticancer Therapy;
-Journal of Transplantation;
-Journal of the American College of Surgeons;
-Journal of Gastrointestinal and Liver Diseases;
-Journal of Clinical Oncology;
-Expert Review of Gastroenterology & Hepatology;
-Surgical Science;
-Nature Reviews Gastroenterology and Hepatology;
-Updates in Surgery.
Autorizzo il trattamento dei miei dati personali ai sensi del Dlgs 196 del 30 giugno 2003.
Seguono le pubblicazioni scientifiche e l’attività didattica.
ELENCO PUBBLICAZIONI
Autori, Titolo, Rivista, PMID
IF
Ravaioli M, Odaldi F, Cucchetti A, Trevisani F, Piscaglia F, De Pace V, Bertuzzo VR, Neri F, Golfieri R, Cappelli A, D'Errico A, Cescon M, Del Gaudio M, Fallani G, Siniscalchi A, Morelli MC, Ciccarese F, Di Marco M, Farinati F, Giannini EG, Pinna AD. Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria. Sci Rep. 2019 7; 9:3781. PMID: 30846792
4.12
Serenari M, Pettinato C, Bonatti C, Zanoni L, Odaldi F, Cucchetti A, Ravaioli M, Fanti S, Pinna AD, Cescon M. Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors. Transplant Proc. 2019 51:167-170. PMID: 30655158
0.80
Serra C, Cucchetti A, Felicani C, Mosconi C, De Cinque A, Golfieri R, Andreone P, Ercolani G, Maroni L, Ravaioli M, D'Errico A, Pinna AD, Cescon M. Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pretransplant Radiology. Liver Transpl. 2019 25:88-97. PMID: 30415500
3.75
Serenari M, Ardiles V, Ravaioli M, Cescon M, De Santibañes E. Rapid but not Harmful: Functional Evaluation With Hepatobiliary Scintigraphy After Accelerated Liver Regeneration Techniques. Ann Surg. 019 PMID: 30893105
9.20
Gramantieri L, Baglioni M, Fornari F, Laginestra MA, Ferracin M, Indio V, Ravaioli M, Cescon M, De Pace V, Leoni S, Coadă CA, Negrini M, Bolondi L, Giovannini C. LncRNAs as novel players in hepatocellular carcinoma recurrence. Oncotarget. 2018 9:35085-35099. PMID: 30416681
5.16
Ravaioli M, Fallani G, Cescon M, Prosperi E, De Pace V, Siniscalchi A, Sangiorgi G, Ferracin M, Ardizzoni A, Morelli MC, Garajová I. Heterotopic auxiliary segment 2-3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases. Surgery. 2018 164:601-603. PMID: 30041968
3.57
Ravaioli M, De Pace V, Comai G, Capelli I, Baraldi O, D'Errico A, Bertuzzo VR, Del Gaudio M, Zanfi C, D'Arcangelo GL, Cuna V, Siniscalchi A, Sangiorgi G, La Manna G. Preliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational study. Transpl Int. 2018 31:1233-1244. PMID: 29957863
3.19
Nigri G, Petrucciani N, Pinna AD, Ravaioli M, Jovine E, Minni F, Grazi GL, Chirletti P, Balzano G, Ferla F, De Carlis L, Tisone G, Napoli N, Boggi U, Ramacciato G. Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units. Int J Surg. 2018 55:103-109. PMID: 29803770.
2.69
Vasuri F, Fittipaldi S, De Pace V, Gramantieri L, Bertuzzo V, Cescon M, Pinna AD, Fiorentino M, D’Errico A, Ravaioli M. Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas. Oncotarget. 2018 9:17895-17905. PMID: 29707155.
5.16
Ercolani G, Zanello M, Serenari M, Cescon M, Cucchetti A, Ravaioli M, Del Gaudio M, D'Errico A, Brandi G, Pinna AD. Ten-Year Survival after Liver Resection for Breast Metastases: A Single-Center Experience. Dig Surg. 2018. [Epub ahead of print] PubMed PMID: 29393171.
2.03
Porcellini E, Laprovitera N, Riefolo M, Ravaioli M, Garajova I, Ferracin M. Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications. Cancer Lett. 2018; 419: 84-95.
6.49
Ravaioli M, Baldassare M, Vasuri F, Pasquinelli G, Laggetta M, Valente S, De Pace V, Neri F, Siniscalchi A, Zanfi C, Bertuzzo VR, Caraceni P, Trerè D, Longobardi P, Pinna AD. Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. Ann Transplant. 2018; 23: 34-44.
1.05
Giovannini C, Fornari F, Dallo R, Gagliardi M, Nipoti E, Vasuri F, Coadă CA, Ravaioli M, Bolondi L, Gramantieri L. MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma. Acta Histochem. 2018; 120: 95-102.
1.65
Ramacciato G, Nigri G, Petrucciani N, Pinna AD, Ravaioli M, Jovine E, Minni F, Grazi GL, Chirletti P, Tisone G, Ferla F, Napoli N, Boggi U. Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement. BMC Surg. 2017; 17: 109.
1.69
Masetti M, Acquaviva G, Visani M, Tallini G, Fornelli A, Ragazzi M, Vasuri F, Grifoni D, Di Giacomo S, Fiorino S, Lombardi R, Tuminati D, Ravaioli M, Fabbri C, Bacchi-Reggiani ML, Pession A, Jovine E, de Biase D. Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. Cancer Biomark. 2018; 21: 323-334.
2.39
Ravaioli M, Capocasale E, Furian L, De Pace V, Iaria M, Spagnoletti G, Salerno MP, Giacomoni A, De Carlis L, Di Bella C, Rostand NM, Boschiero L, Pasquale G, Bosio A, Collini A, Carmellini M, Airoldi A, Bondonno G, Ditonno P, Impedovo SV, Beretta C, Giussani A, Socci C, Parolini DC, Abelli M, Ticozzelli E, Baccarani U, Adani GL, Caputo F, Buscemi B, Frongia M, Solinas A, Gruttadauria S, Spada M, Pinna AD, Romagnoli J. Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy. Nephrol Dial Transplant. 2017; 32: 2126-2131.
4.60
Ravaioli M, De Pace V, Comai G, Busutti M, Del Gaudio M, Amaduzzi A, Cucchetti A, Siniscalchi A, La Manna G, D'Errico AAD, Pinna AD. Successful Dual Kidney Transplantation After Hypothermic Oxygenated Perfusion of Discarded Human Kidneys. Am J Case Rep. 2017; 18: 1009-1013.
N.A.
Cuna V, Comai G, Cappuccilli M, Baraldi O, Capelli I, De Liberali M, Gasperoni L, Conte D, Ravaioli M, Pinna AD, La Manna G. Fifteen-Year Analysis of Deceased Kidney Donation: A Single Transplant Center Experience in a Region of Northern Italy. Med Sci Monit. 2017; 23: 4482-4489.
1.89
Ravaioli M, Cucchetti A, Pinna AD, De Pace V, Neri F, Barbera MA, Maroni L, Frega G, Palloni A, De Lorenzo S, Ripoli MC, Pantaleo MA, Cescon M, Del Gaudio M, Brandi G. The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation. Sci Rep. 2017; 7: 11305.
4.12
Siniscalchi A, Gamberini L, Laici C, Loforte A, Ravaioli M. Thrombolysis for acute pulmonary embolism after major hepatic surgery. J Clin Anesth. 2017; 42: 44-45.
1.81
Neri F, Furian L, Cavallin F, Ravaioli M, Silvestre C, Donato P, La Manna G, Pinna AD, Rigotti P. How does age affect the outcome of kidney transplantation in elderly recipients? Clin Transplant. 2017; 31(10).
1.51
Ravaioli M, De Pace V, Pinna AD. From six thousand transaminases level to three hundred after liver transplantation: a new era seems to be open. Updates Surg. 2017; 69: 549-550.
1.76
Siniscalchi A, Gamberini L, Bardi T, Laici C, Ravaioli M, Bacchi Reggiani ML, Faenza S. Post-reperfusion syndrome during orthotopic liver transplantation, which definition best predicts postoperative graft failure and recipient mortality? J Crit Care. 2017; 41: 156-160.
2.87
Comai G, Ravaioli M, Baraldi O, Cuna V, Gasperoni L, D''Arcangelo GL, Cappuccilli M, Pinna AD, Ronco C, La Manna G. Treatment of Acute Antibody-Mediated Rejection. Contrib Nephrol. 2017; 190: 156-167.
1.73
Bertuzzo VR, Giannella M, Cucchetti A, Pinna AD, Grossi A, Ravaioli M, Del Gaudio M, Cristini F, Viale P, Cescon M. Impact of preoperative infection on outcome after liver transplantation. Br J Surg. 2017 Jan;104(2):e172-e181. PMID: 28121031.
5.43
Fornari F, Pollutri D, Patrizi C, La Bella T, Marinelli S, Casadei Gardini A, Marisi G, Baron Toaldo M, Baglioni M, Salvatore V, Callegari E, Baldassarre M, Galassi M, Giovannini C, Cescon M, Ravaioli M, Negrini M, Bolondi L, Gramantieri L. In hepatocellular carcinoma miR-221 modulates Sorafenib resistance through inhibition of caspase-3 mediated apoptosis. Clin Cancer Res. 2017 Jan 17. pii: clincanres.1464.2016. PMID: 28096271.
10.19
Bertuzzo VR, Cescon M, Odaldi F, Di Laudo M, Cucchetti A, Ravaioli M, Del Gaudio M, Ercolani G, D'Errico A, Pinna AD. Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era. Ann Surg. 2017 Feb;265(2):388-396. PMID: 28059967.
9.20
Di Laudo M, Ravaioli M, La Manna G, Comai G, Cescon M, Del Gaudio M, Bertuzzo V, Zanfi C, Cucchetti A, Pinna AD. Reply. Liver Transpl. 2017 Feb;23(2):268-269. PMID: 27884044.
3.75
Chiereghin A, Petrisli E, Ravaioli M, Morelli MC, Turello G, Squarzoni D, Piccirilli G, Ambretti S, Gabrielli L, Pinna AD, Landini MP, Lazzarotto T. Infectious agents after liver transplant: etiology, timeline and patients' cell-mediated immunity responses. Med Microbiol Immunol. 2017 Feb;206(1):63-71. PubMed PMID: 27783145.
3.20
Cucchetti A, Cescon M, Colecchia A, Neri F, Cappelli A, Ravaioli M, Mazzotti F, Ercolani G, Festi D, Pinna AD. Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome. Ultraschall Med. 2016 May 3. PMID: 27139376.
4.38
Giovannini C, Minguzzi M, Genovese F, Baglioni M, Gualandi A, Ravaioli M, Milazzo M, Tavolari S, Bolondi L, Gramantieri L. Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma. Oncotarget. 2016 Jun 28;7(26):39609-39626. PMID: 27167202.
5.16
Ravaioli M, Grande G, Di Gioia P, Cucchetti A, Cescon M, Ercolani G, Del Gaudio M, Morelli C, Pinna AD. Risk Avoidance and Liver Transplantation: A Single-center Experience in a National Network. Ann Surg. 2016 Nov;264(5):778-786. PMID: 27429038.
9.20
Maroni L, Ravaioli M, Pinna AD. Why is pancreatic adenocarcinoma not screened for earlier? Expert Rev Anticancer Ther. 2016 Oct;16(10):1003-4. PubMed PMID: 27552648.
2.34
Ravaioli M, Serenari M, Cescon M, Savini C, Cucchetti A, Ercolani G, Del Gaudio M, Casati A, Pinna AD. Liver and Vena Cava En Bloc Resection for an Invasive Leiomyosarcoma Causing Budd-Chiari Syndrome, Under Veno-Venous Bypass and Liver Hypothermic Perfusion: Liver Hypothermic Perfusion and Veno-Venous Bypass for Inferior Vena Cava Leiomyosarcoma. Ann Surg Oncol. 2017 Feb;24(2):556-557. PMID: 27431416.
3.85
Capocasale E, Berardinelli L, Beretta C, Berloco P, Boggi U, Boschiero L, Bretto P, Carmellini M, Citterio F, Concone G, De Carlis L, De Rosa P, Del Gaudio M, Di Sandro S, Di Tonno P, Faenza A, Famulari A, Giacomoni A, Giovannoni M, Iaria M, Lauterio A, Lasaponara F, Mazzoni MP, Nicita G, Orsenigo E, Parolini DC, Pietrabissa A, Pinna AD, Pisani F, Ravaioli M, Rigotti P, Romagnoli J, Rossetti O, Secchi A, Socci C, Vistoli F. [Surgical overview on kidney and pancreas transplantation]. G Ital Nefrol. 2016 May-Jun;33(3). PMID: 27374387.
0.11
Di Laudo M, Ravaioli M, La Manna G, Comai G, Cescon M, Del Gaudio M, Zanfi C, Cucchetti A, Ercolani G, Pinna AD. Combined liver-dual kidney transplant: Role in expanded donors. Liver Transpl. 2017 Jan;23(1):28-34. PMID: 27113672.
3.75
Cucchetti A, Trevisani F, Bucci L, Ravaioli M, Farinati F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Maida M, Felder M, Morisco F, Gasbarrini A, Gemini S, Foschi FG, Missale G, Masotto A, Affronti A, Bernardi M, Pinna AD; Italian Liver Cancer Group. Years of life that could be saved from prevention of hepatocellular carcinoma. Aliment Pharmacol Ther. 2016 Apr;43(7):814-24. PMID: 26864152.
7.35
Bertuzzo VR, Cescon M, Odaldi F, Di Laudo M, Cucchetti A, Ravaioli M, Del Gaudio M, Ercolani G, D'Errico A, Pinna AD. Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era. Ann Surg. 2016 Mar 7. [Epub ahead of print] PMID: 26954895.
9.20
Cucchetti A, Ercolani G, Taffurelli G, Serenari M, Maroni L, Pezzilli R, Del Gaudio M, Ravaioli M, Cescon M, Pinna AD. A comprehensive analysis on expected years of life lost due to pancreatic cancer. Pancreatology. 2016 May-Jun;16(3):449-53. PMID: 26951889.
2.40
Ramacciato G, Nigri G, Petrucciani N, Pinna AD, Ravaioli M, Jovine E, Minni F, Grazi GL, Chirletti P, Tisone G, Napoli N, Boggi U. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients. Ann Surg Oncol. 2016 Jun;23(6):2028-37. PMID: 26893222.
3.85
Cucchetti A, Ercolani G, Cescon M, Brandi G, Taffurelli G, Maroni L, Ravaioli M, Pezzilli R, Pinna AD. Estimation of the Survival Benefit Obtainable From Screening for the Early Detection of Pancreatic Cancer. Pancreas. 2016 May-Jun;45(5):714-9. PMID: 26646274.
2.73
Piscaglia F, Svegliati-Baroni G, Barchetti A, Pecorelli A, Marinelli S, Tiribelli C, Bellentani S; HCC-NAFLD Italian Study Group. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study. Hepatology. 2016 Mar;63(3):827-38. PMID: 26599351.
2.09
Capelli I, Battaglino G, Baraldi O, Ravaioli M, Cuna V, Moretti I, Angeletti A, Mencarelli F, Pasini A, Montini G, Pinna AD, La Manna G. [Kidney Transplantation and inborn errors of metabolism]. G Ital Nefrol. 2015;32 Suppl 64. PMID: 26479053.
0.11
Vasuri F, Fittipaldi S, Giunchi F, Monica M, Ravaioli M, Degiovanni A, Bonora S, Golfieri R, Bolondi L, Grigioni WF, Pasquinelli G, D'Errico-Grigioni A. Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers. J Clin Pathol. 2016 Feb;69(2):102-8. PMID: 26243063.
2.89
Cucchetti A, Ross LF, Thistlethwaite JR Jr, Vitale A, Ravaioli M, Cescon M, Ercolani G, Burra P, Cillo U, Pinna AD. Age and equity in liver transplantation: An organ allocation model. Liver Transpl. 2015 Oct;21(10):1241-9. PMID: 26174971.
3.75
Capelli I, Battaglino G, Baraldi O, Ravaioli M, Cuna V, Moretti I, Angeletti A, Mencarelli F, Pasini A, Montini G, Pinna AD, La Manna G. [Kidney Transplantation and inborn errors of metabolism]. G Ital Nefrol. 2015 Mar-Apr;32(2). PMID: 26005941.
0.11
Ravaioli M, Neri F, Lazzarotto T, Bertuzzo VR, Di Gioia P, Stacchini G, Morelli MC, Ercolani G, Cescon M, Chiereghin A, Del Gaudio M, Cucchetti A, Pinna AD. Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. Transplantation. 2015 Aug;99(8):1625-32. PMID: 25757214.
3.96
Farinati F, Vanin V, Giacomin A, Pozzan C, Cillo U, Vitale A, Di Nolfo AM, Del Poggio P, Benvegnu' L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. Liver Int. 2015 Jan;35(1):223-31. PMID: 25074434.
4.50
Giovannini C, Minguzzi M, Baglioni M, Fornari F, Giannone F, Ravaioli M, Cescon M, Chieco P, Bolondi L, Gramantieri L. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. Oncotarget. 2014 Nov 15;5(21):10607-20. PMID: 25431954.
5.16
Ravaioli M, Pinna AD, Francioni G, Montorsi M, Veneroni L, Grazi GL, Palini GM, Gavazzi F, Stacchini G, Ridolfi C, Serenari M, Zerbi A. A partnership model between high- and low-volume hospitals to improve results in hepatobiliary pancreatic surgery. Ann Surg. 2014 Nov;260(5):871-5; discussion 875-7. PMID: 25243551.
9.20
Pinna AD, Neri F, Ravaioli M. A bridge too far: We have overstepped the line for extended deceased donors. Liver Transpl. 2014 Nov;20 Suppl 2:S6-8. PMID: 25219495.
3.75
Lauro A, Zanfi C, Dazzi A, di Gioia P, Stanghellini V, Pironi L, Ercolani G, Gaudio MD, Ravaioli M, Faenza S, di Simone M, Pinna AD. Disease-related intestinal transplant in adults: results from a single center. Transplant Proc. 2014 Jan-Feb;46(1):245-8. PMID: 24507060.
0.80
Farinati F, Vanin V, Giacomin A, Pozzan C, Cillo U, Vitale A, Di Nolfo AM, Del Poggio P, Benvegnu' L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. Liver Int. 2015 Jan;35(1):223-31. PMID: 25074434.
4.50
Ravaioli M, Ercolani G, Neri F, Cescon M, Stacchini G, Del Gaudio M, Cucchetti A, Pinna AD. Liver transplantation for hepatic tumors: a systematic review. World J Gastroenterol. 2014 May 14;20(18):5345-52. PMID: 24833864.
3.30
Cucchetti A, Trevisani F, Pecorelli A, Erroi V, Farinati F, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Giannini EG, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Baroni GS, Virdone R, Bernardi M, Pinna AD; Italian Liver Cancer Group. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. J Hepatol. 2014 Aug;61(2):333-41. PMID: 24717522.
15.04
Neri F, Ravaioli M, Pinna AD. The multiple aspects of liver transplantation for hepatocellular carcinoma: comments on the recommendations from the consensus conference. Hepatobiliary Surg Nutr. 2014 Feb;3(1):1-3. PMID: 24696008.
N.A.
Biselli M, Dall'Agata M, Gramenzi A, Gitto S, Liberati C, Brodosi L, Ravaioli M, Gambato M, Montalti R, Pinna AD, Burra P, Gerunda GE, Cillo U, Andreone P, Bernardi M. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. Liver Int. 2015 Jan;35(1):184-91. PMID: 24650058.
4.50
Bertuzzo VR, Ravaioli M, Morelli MC, Calderaro A, Viale P, Pinna AD. Pregnant woman saved with liver transplantation from acute liver failure due to hepatitis E virus. Transpl Int. 2014 Sep;27(9):e87-9. PMID: 24606386.
3.19
Del Poggio P, Olmi S, Ciccarese F, Di Marco M, Rapaccini GL, Benvegnù L, Borzio F, Farinati F, Zoli M, Giannini EG, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Group. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014 Nov;12(11):1927-33.e2. PMID: 24582947.
7.68
Cescon M, Ercolani G, Cucchetti A, Ravaioli M, Pinna AD. Is really full right full left split liver transplantation a valuable tool to increase organ availability? Hepatobiliary Surg Nutr. 2013 Aug;2(4):182-3. PMID: 24570942.
0
Cucchetti A, Siniscalchi A, Cescon M, Mazzotti F, Ercolani G, Ravaioli M, Faenza S, Pinna AD. Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy. Minerva Anestesiol. 2014 Jun;80(6):645-54. PMID: 24280819.
2.69
Cescon M, Bertuzzo VR, Ercolani G, Ravaioli M, Odaldi F, Pinna AD. Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis. World J Gastroenterol. 2013 Dec 28;19(48):9174-82. PMID: 24409045.
3.30
Cucchetti A, Vitale A, Cescon M, Gambato M, Maroni L, Ravaioli M, Ercolani G, Burra P, Cillo U, Pinna AD. Can liver transplantation provide the statistical cure? Liver Transpl. 2014 Feb;20(2):210-7. PMID: 24166895.
3.75
Cazzagon N, Trevisani F, Maddalo G, Giacomin A, Vanin V, Pozzan C, Poggio PD, Rapaccini G, Nolfo AM, Benvegnù L, Zoli M, Borzio F, Giannini EG, Caturelli E, Chiaramonte M, Foschi FG, Cabibbo G, Felder M, Ciccarese F, Missale G, Baroni GS, Morisco F, Pecorelli A, Farinati F; Italian Liver Cancer (ITA.LI.CA) Group. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. Liver Int. 2013 Oct;33(9):1420-7. PMID: 23758775.
4.50
Giannini EG, Savarino V, Farinati F, Ciccarese F, Rapaccini G, Marco MD, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int. 2013 Nov;33(10):1594-600. PMID: 23654354.
4.50
Catena F, Coccolini F, Montori G, Vallicelli C, Amaduzzi A, Ercolani G, Ravaioli M, Del Gaudio M, Schiavina R, Brunocilla E, Liviano G, Feliciangeli G, Pinna AD. Kidney preservation: review of present and future perspective. Transplant Proc. 2013 Nov;45(9):3170-7. PMID: 24182779.
0.80
La Manna G, Comai G, Cappuccilli ML, Liviano D'Arcangelo G, Fabbrizio B, Valentini C, Carretta E, Ravaioli M, Scolari MP, Ridolfi L, Feliciangeli G, Grigioni FW, Pinna AD, Stefoni S. Prediction of three-year outcome of renal transplantation from optimal donors versus expanded criteria donors. Am J Nephrol. 2013;37(2):158-66. PMID: 23392180.
2.88
Del Gaudio M, Ravaioli M, Ercolani G, Cescon M, Amaduzzi A, Neri F, Pellegrini
S, Feliciangeli G, Lamanna G, Morelli C, D'Arcangelo GL, Comai G, Cucchi M, Stefoni S, Pinna AD. Induction therapy with alemtuzumab (campath) in combined liver-kidney transplantation: University of Bologna experience. Transplant Proc.
2013 Jun;45(5):1969-70. PMID: 23769085.
0.80
Ravaioli M, Serenari M, Cescon M, Martin Suarez S, Cucchetti A, Ercolani G, Del Gaudio M, Catena F, Morelli C, Arpesella G, Pinna AD. Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. Case Rep Transplant. 2012; 2012:849619. PMID: 23259144.
N.A.
Ramacciato G, D'Angelo F, Petrucciani N, Aurello P, Ravaioli M. Extrapleural solitary fibrous tumor of the bile duct arisen on a choledochal cyst. Am Surg. 2012 Nov;78(11): E487-9. PMID: 23089429.
0.60
Cescon M, Cucchetti A, Ravaioli M, Pinna AD. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate. J Hepatol. 2013 Mar;58(3):609-18. PMID: 23041304.
15.04
Bertuzzo VR, Cescon M, Morelli MC, Di Gioia P, Tamè M, Lorenzini S, Andreone P, Ercolani G, Del Gaudio M, Ravaioli M, Cucchetti A, Dazzi A, D'Errico-Grigioni A, Pinna AD. Long-term antiviral treatment for recurrent hepatitis C after liver transplantation. Dig Liver Dis. 2012 Oct;44(10):861-7. PMID: 22819767.
3.28
Muroni M, Ravaioli M, Del Gaudio M, Nigri G, D'Angelo F, Uccini S, Ramacciato G. Pancreas-preserving segmental duodenectomy for gastrointestinal stromal tumor of the duodenum and splenectomy for splenic angiosarcoma. Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):325-9. PMID: 22672829.
1.50
Giannini EG, Marenco S, Borgonovo G, Savarino V, Farinati F, Del Poggio P, Rapaccini GL, Anna Di Nolfo M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology. 2012 Oct;56(4):1371-9. PMID: 22535689.
2.09
Ramacciato G, D'Angelo F, Baldini R, Petrucciani N, Antolino L, Aurello P, Nigri G, Bellagamba R, Pezzoli F, Balesh A, Cucchetti A, Cescon M, Del Gaudio M, Ravaioli M, Pinna AD. Hepatocellular carcinomas and primary liver tumors as predictive factors for postoperative mortality after liver resection: a meta-analysis of more than 35,000 hepatic resections. Am Surg. 2012 Apr;78(4):456-67. PMID: 22472405.
0.60
La Torre M, Nigri G, Ferrari L, Cosenza G, Ravaioli M, Ramacciato G. Hospital volume, margin status, and long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg. 2012 Feb;78(2):225-9. PMID: 22369834.
0.60
Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S, Callegari E, Cescon M, Ravaioli M, Croce CM, Bolondi L, Gramantieri L. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol. 2012 Jul;227(3):275-85. PMID: 22262409.
6.25
Cucchetti A, Ercolani G, Cescon M, Bigonzi E, Peri E, Ravaioli M, Pinna AD. Impact of subcentimeter margin on outcome after hepatic resection for colorectal metastases: a meta-regression approach. Surgery. 2012 May;151(5):691-9. PMID: 22261294.
3.57
Farinati F, Giacomin A, Vanin V, Sergio A, Burra P, Cillo U, Di Nolfo A, Del Poggio P, Benvegnu L, Zoli M, Borzio F, Giannini EG, Caturelli E, Cazzagon N, Rapaccini GL, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy. Eur J Gastroenterol Hepatol. 2012 Feb;24(2):195-202. PMID: 22108511.
2.01
Cucchetti A, Cescon M, Bigonzi E, Piscaglia F, Golfieri R, Ercolani G, Cristina Morelli M, Ravaioli M, Daniele Pinna A. Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy. Liver Transpl. 2011 Nov;17(11):1344-54. PMID: 21837731.
3.75
Ravaioli M, Francioni G. Should open mesh repair with local anesthesia be the standard of care for randomized trials? Ann Surg. 2011 Aug;254(2):384-5; PMID: 21772133.
9.20
Cescon M, Zanello M, Grazi GL, Cucchetti A, Ravaioli M, Ercolani G, Del Gaudio M, Lauro A, Morelli MC, Pinna AD. Impact of very advanced donor age on hepatic artery thrombosis after liver transplantation. Transplantation. 2011 Aug 27;92(4):439-45. PMID: 21712754.
3.96
Vitale A, Morales RR, Zanus G, Farinati F, Burra P, Angeli P, Frigo AC, Del Poggio P, Rapaccini G, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Giannini EG, Caturelli E, Chiaramonte M, Trevisani F, Cillo U; Italian Liver Cancer group. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. Lancet Oncol. 2011 Jul;12(7):654-62. PMID: 21684210.
36.41
Ravaioli M, Ercolani G, Cescon M, Del Gaudio M, Cucchetti A, Ramacciato G, Francioni G, Pinna AD. "Double common bile duct: a pitfall during liver transplantation and cholecystectomy". Surgery. 2011 Jul;150(1):139-40. PMID: 21683862.
3.57
Nigri G, Romano C, Valabrega S, Aurello P, D'Angelo F, Ravaioli M, Ramacciato G. Cholangiocarcinoma in HIV-positive patients: are these conditions related? Am Surg. 2011 Jun;77(6):e105-6. PMID: 21679618.
0.60
Ercolani G, Cucchetti A, Cescon M, Peri E, Brandi G, Del Gaudio M, Ravaioli M, Zanello M, Pinna AD. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. Eur J Cancer. 2011 Oct;47(15):2291-8. PMID: 21652204.
7.19
Bertuzzo VR, Cescon M, Ravaioli M, Grazi GL, Ercolani G, Del Gaudio M, Cucchetti A, D'Errico-Grigioni A, Golfieri R, Pinna AD. Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. Transplantation. 2011 Jun 15;91(11):1279-85. PMID: 21617590.
3.96
Aurello P, Petrucciani N, D'Angelo F, Nigri GR, Vitale V, Ravaioli M, Ramacciato G. Management of solitary splenic metastasis from ovarian carcinoma: is there an indication for splenectomy? Am Surg. 2010 Sep;76(9):E173-5. PMID: 21396277.
0.60
D'Angelo F, Petrucciani N, Aurello P, Nigri GR, Romano C, Antolino L, Ravaioli M, Ramacciato G. Treatment of achalasia with extreme megaesophagus: heller myotomy or esophagectomy? Am Surg. 2011 Mar;77(3):362-4. PMID: 21375855.
0.60
Ramacciato G, Mercantini P, Petrucciani N, Nigri GR, Kazemi A, Muroni M, Del Gaudio M, Balesh A, Cescon M, Cucchetti A, Ravaioli M. Risk factors of pancreatic fistula after pancreaticoduodenectomy: a collective review. Am Surg. 2011 Mar;77(3):257-69. PMID: 21375833.
0.60
Golfieri R, Cappelli A, Cucchetti A, Piscaglia F, Carpenzano M, Peri E, Ravaioli M, D'Errico-Grigioni A, Pinna AD, Bolondi L. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas. Hepatology. 2011 May;53(5):1580-9. PMID: 21351114.
2.09
Ravaioli M, Zanello M, Grazi GL, Ercolani G, Cescon M, Del Gaudio M, Cucchetti A, Pinna AD. Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. Ann Surg. 2011 Feb;253(2):378-84. PMID: 21183851.
9.20
Giannini EG, Savarino V, Risso D, Di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer (ITA.LI.CA.) group. Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian study. Liver Int. 2011 Feb;31(2):192-6. PMID: 21143580.
4.50
Ramacciato G, Nigri G, Bellagamba R, Petrucciani N, Ravaioli M, Cescon M, Del Gaudio M, Ercolani G, Di Benedetto F, Cautero N, Quintini C, Cucchetti A, Lauro A, Miller C, Pinna AD. Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinoma. Am Surg. 2010 Nov;76(11):1260-8. PMID: 21140696.
0.60
Ramacciato G, Mercantini P, Petrucciani N, Ravaioli M, Cucchetti A, Del Gaudio M, Cescon M, Ziparo V, Pinna AD. Does surgical resection have a role in the treatment of large or multinodular hepatocellular carcinoma? Am Surg. 2010 Nov;76(11):1189-97. PMID: 21140683.
0.60
Cucchetti A, Zanello M, Cescon M, Ercolani G, Del Gaudio M, Ravaioli M, Grazi GL, Pinna AD. Improved diagnostic imaging and interventional therapies prolong survival after resection for hepatocellular carcinoma in cirrhosis: the university of bologna experience over 10 years. Ann Surg Oncol. 2011 Jun;18(6):1630-7. PMID: 21136178.
3.85
Colecchia A, Scaioli E, Montrone L, Vestito A, Di Biase AR, Pieri M, D'Errico-Grigioni A, Bacchi-Reggiani ML, Ravaioli M, Grazi GL, Festi D. Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment. J Hepatol. 2011 Feb;54(2):300-5. PMID: 21056498.
15.04
Cescon M, Ravaioli M, Grazi GL, Ercolani G, Cucchetti A, Bertuzzo V, Vetrone G, Del Gaudio M, Vivarelli M, D'Errico-Grigioni A, Dazzi A, Di Gioia P, Lauro A, Pinna AD. Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. J Transplant. 2010;2010. pii: 904152. PMID: 20862199.
1.31
Ravaioli M, Ercolani G, Grazi GL, Cescon M, Dazzi A, Zanfi C, Pinna AD.
Safety and prognostic role of regional lymphadenectomy for primary and metastatic
liver tumors. Updates Surg. 2010 Aug;62(1):27-34. PMID: 20845098.
1.76
Biselli M, Gitto S, Gramenzi A, Di Donato R, Brodosi L, Ravaioli M, Grazi GL, Pinna AD, Andreone P, Bernardi M. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? Liver Transpl. 2010 Aug;16(8):964-73. PMID: 20677287.
3.75
Ercolani G, Vetrone G, Grazi GL, Aramaki O, Cescon M, Ravaioli M, Serra C, Brandi G, Pinna AD. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg. 2010 Jul;252(1):107-14. PMID: 20531002.
9.20
Santi V, Trevisani F, Gramenzi A, Grignaschi A, Mirici-Cappa F, Del Poggio P, Di Nolfo MA, Benvegnù L, Farinati F, Zoli M, Giannini EG, Borzio F, Caturelli E, Chiaramonte M, Bernardi M; Italian Liver Cancer (ITA.LI.CA) Group. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. J Hepatol. 2010 Aug;53(2):291-7. PMID: 20483497.
15.04
Ercolani G, Zanello M, Grazi GL, Cescon M, Ravaioli M, Del Gaudio M, Vetrone G, Cucchetti A, Brandi G, Ramacciato G, Pinna AD. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Sci. 2010 May;17(3):329-37. PMID: 20464563.
2.87
Vivarelli M, Zanello M, Zanfi C, Cucchetti A, Ravaioli M, Del Gaudio M, Cescon M, Lauro A, Montanari E, Grazi GL, Pinna AD. Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary? World J Gastroenterol. 2010 May 7;16(17):2146-50. PMID: 20440855.
3.30
Piscaglia F, Gianstefani A, Ravaioli M, Golfieri R, Cappelli A, Giampalma E, Sagrini E, Imbriaco G, Pinna AD, Bolondi L; Bologna Liver Transplant Group. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. Liver Transpl. 2010 May;16(5):658-67. PMID: 20440775.
3.75
Cucchetti A, Piscaglia F, Grigioni AD, Ravaioli M, Cescon M, Zanello M, Grazi GL, Golfieri R, Grigioni WF, Pinna AD. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. J Hepatol. 2010 Jun;52(6):880-8. PMID: 20409605.
15.04
Vivarelli M, Dazzi A, Zanello M, Cucchetti A, Cescon M, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. Transplantation. 2010 Jan 27;89(2):227-31. PMID: 20098287.
3.96
Aurello P, Bellagamba R, Rossi Del Monte S, D'Angelo F, Nigri G, Cicchini C, Ravaioli M, Ramacciato G. Apoptosis and microvessel density in gastric cancer: correlation with tumor stage and prognosis. Am Surg. 2009 Dec;75(12):1183-8. PMID: 19999909.
0.60
Fiorentino M, Vasuri F, Ravaioli M, Ridolfi L, Grigioni WF, Pinna AD, D'Errico-Grigioni A. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Liver Transpl. 2009 Dec;15(12):1821-5. PMID: 19938115.
3.75
Ravaioli M, Cescon M, Grazi GL, Ercolani G, Del Gaudio M, Cucchetti A, Vivarelli M, Di Gioia P, Vetrone G, Pinna AD. Liver transplantation with left lateral segments in adults: a risk or a possibility? Transplantation. 2009 Sep 27;88(6):849-50. PMID: 19920788.
3.96
Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD. Survival benefit after liver transplantation: a single European center experience. Transplantation. 2009 Sep 27;88(6):826-34. PMID: 19920783.
3.96
Cescon M, Grazi GL, Ravaioli M, Ercolani G, Del Gaudio M, Vivarelli M, Cucchetti A, Zanello M, Vetrone G, Lauro A, Pinna AD. Conventional split liver transplantation for two adult recipients: a recent experience in a single European center. Transplantation. 2009 Nov 15;88(9):1117-22. PMID: 19898208.
3.96
Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, Grazi GL, Pinna AD. Is portal hypertension a contraindication to hepatic resection? Ann Surg. 2009 Dec;250(6):922-8. PMID: 19855258.
9.20
Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, Ravaioli M, Zanello M, Andreone P, Capussotti L, Pinna AD. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience. Arch Surg. 2009 Oct;144(10):906-13. PMID: 19841357.
8.50
Aurello P, Rossi Del Monte S, D'Angelo F, Cicchini C, Ciardi A, Bellagamba R, Ravaioli M, Ramacciato G. Vascular endothelial growth factor C and microvessel density in gastric carcinoma: correlation with clinicopathological factors. Our experience and review of the literature. Oncol Res. 2009;17(9):405-11. PMID: 19718947.
3.14
Aurello P, Bellagamba R, D'Angelo F, Cicchini C, Nigri G, Ravaioli M, Ramacciato G. Synchronous right trisegmentectomy and gastrectomy for huge hepatic metastasis as first manifestation of advanced gastric cancer. Am Surg. 2009 Jul;75(7):629-30. PMID: 19655612.
0.60
Ravaioli M, Grazi GL, Cescon M, Ercolani G, Pinna AD, Piscaglia F, Trevisani F. Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice? Ann Surg. 2009 Aug;250(2):348; author reply 348-9. PMID: 19638902.
9.20
Biselli M, Gramenzi A, Del Gaudio M, Ravaioli M, Vitale G, Gitto S, Grazi GL, Pinna AD, Andreone P, Bernardi M; Bologna Liver Transplantation Group. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study. J Clin Gastroenterol. 2010 Jan;44(1):52-7. PMID: 19581813.
2.96
Cescon M, Grazi GL, Cucchetti A, Vetrone G, Ravaioli M, Ercolani G, Morelli MC, Piscaglia F, Tamè M, Pinna AD. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation. Liver Transpl. 2009 Jul;15(7):782-9. PMID: 19562715.
3.75
Kimura T, Lauro A, Cescon M, Zanfi C, Dazzi A, Ercolani G, Grazi GL, Vivarelli M, Ravaioli M, Del Gaudio M, Cucchetti A, Zanello M, LaBarba G, Pironi L, Lazzarotto T, Pinna AD. Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. Clin Transplant. 2009 Jun-Jul;23(3):420-5. PMID: 19537304.
1.51
Grazi GL, Vetrone G, d'Errico A, Caprara G, Ercolani G, Cescon M, Ravaioli M, Del Gaudio M, Vivarelli M, Zanello M, Pinna AD. Nested stromal-epithelial tumor (NSET) of the liver: a case report of an extremely rare tumor. Pathol Res Pract. 2010 Apr 15;206(4):282-6. PMID: 19487085.
1.46
Cucchetti A, Vivarelli M, Ravaioli M, Cescon M, Ercolani G, Piscaglia F, Del Gaudio M, Grazi GL, Ridolfi L, Pinna AD. Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? Clin Transplant. 2009 Aug-Sep;23(4):519-24. PMID: 19486345.
1.51
Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M, Del Gaudio M, Pinna AD. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg. 2009 Jun;249(6):995-1002. PMID: 19474679.
9.20
Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F; Italian Liver Cancer group. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? Eur J Gastroenterol Hepatol. 2009 Oct;21(10):1212-8. PMID: 19465859.
2.01
Giannini EG, Marabotto E, Savarino V, Trevisani F, di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M; Italian Liver Cancer (ITALICA) Group. Hepatocellular carcinoma in patients with cryptogenic cirrhosis. Clin Gastroenterol Hepatol. 2009 May;7(5):580-5. PMID: 19418607.
7.68
Cescon M, Carini R, Grazi G, Caraceni P, Alchera E, Gasloli G, Ravaioli M, Tuci F, Imarisio C, Dal Ponte C, Pertosa AM, Bernardi M, Pinna AD, Albano E. Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning. J Hepatol. 2009 May;50(5):937-47. PMID: 19303157.
15.04
Ramacciato G, Nigri G, Ravaioli M, Del Gaudio M. In favor of the Jarnagin-Blumgart classification. Ann Surg. 2009 Apr;249(4):697-8; author reply 698-9. PMID: 19300209.
9.20
Ravaioli M, Grazi GL, Cescon M, Trevisani F, Piscaglia F, Ercolani G, Pinna AD. Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection. Hepatology. 2009 Mar;49(3):1056. PMID: 19241485.
2.09
Ramacciato G, Mercantini P, Petrucciani N, Giaccaglia V, Nigri G, Ravaioli M, Cescon M, Cucchetti A, Del Gaudio M. Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? Ann Surg Oncol. 2009 Apr;16(4):817-25. PMID: 19156463.
3.85
Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, Zanello M, Ravaioli M, Capussotti L, Pinna AD. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. Arch Surg. 2009 Jan;144(1):57-63; discussion 63. PMID: 19153326.
8.50
Ravaioli M, Grazi GL, Vetrone G, Kimura T, Zanello M, Ercolani G, Cescon M, Varotti G, Del Gaudio M, Tuci F, Cucchetti A, La Barba G, Vivarelli M, Lauro A, Ramacciato G, Pinna AD. A new liver transplant priority for patients with hepatocellular carcinoma. Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1742-5. PMID: 19102382.
0.79
Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE,
Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P; Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009 Jan;10(1):35-43. PMID: 19058754.
36.41
Ravaioli M, Grazi GL, Cescon M, Cucchetti A, Ercolani G, Fiorentino M, Panzini I, Vivarelli M, Ramacciato G, Del Gaudio M, Vetrone G, Zanello M, Dazzi A, Zanfi C, Di Gioia P, Bertuzzo V, Lauro A, Morelli C, Pinna AD. Liver transplantations with donors aged 60 years and above: the low liver damage strategy. Transpl Int. 2009 Apr;22(4):423-33. PMID: 19040483.
3.19
Cucchetti A, Piscaglia F, Caturelli E, Benvegnù L, Vivarelli M, Ercolani G, Cescon M, Ravaioli M, Grazi GL, Bolondi L, Pinna AD. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol. 2009 Feb;16(2):413-22. PMID: 19034578.
3.85
Vivarelli M, Cucchetti A, La Barba G, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Ann Surg. 2008 Nov;248(5):857-62. PMID: 18948815.
9.20
Zanfi C, Cescon M, Lauro A, Dazzi A, Ercolani G, Grazi GL, Del Gaudio M, Ravaioli M, Cucchetti A, La Barba G, Zanello M, Cipriani R, Pinna AD. Incidence and management of abdominal closure-related complications in adult intestinal transplantation. Transplantation. 2008 Jun 15;85(11):1607-9. PMID: 18551067.
3.96
Cescon M, Grazi GL, Cucchetti A, Ravaioli M, Ercolani G, Vivarelli M, D'Errico A, Del Gaudio M, Pinna AD. Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl. 2008 May;14(5):672-9. PMID: 18433035.
3.75
Ercolani G, Ravaioli M, Grazi GL, Cescon M, Del Gaudio M, Vetrone G, Zanello M, Pinna AD. Use of vascular clamping in hepatic surgery: lessons learned from 1260 liver resections. Arch Surg. 2008 Apr;143(4):380-7; discussion 388. PMID: 18427026.
8.50
Ramacciato G, Nigri G, Di Santo V, Piccoli M, Pansadoro V, Buniva P, Bellagamba R, Cescon M, Ercolani G, Cucchetti A, Lauro A, Del Gaudio M, Ravaioli M, Valabrega S, D'Angelo F, Aurello P, Stigliano A, Toscano V, Melotti G. [Minimally invasive adrenalectomy: transperitoneal vs. retroperitoneal approach]. Chir Ital. 2008 Jan-Feb;60(1):15-22. Italian. PMID: 18389743.
0.29
Ramacciato G, D'Angelo F, Aurello P, Nigri G, Valabrega S, Pezzoli F, Ravaioli M, Cescon M, Cucchetti A, Lauro A, Del Gaudio M, Ercolani G. [Right hemicolectomy for colon cancer: a prospective randomised study comparing laparoscopic vs. open technique]. Chir Ital. 2008 Jan-Feb;60(1):1-7. Italian. PMID: 18389741.
0.29
Ercolani G, Ravaioli M, Grazi GL, Cescon M, Varotti G, Del Gaudio M, Vetrone G, Zanello M, Principe A, Pinna AD. The role of liver resections for metastases from lung carcinoma. HPB (Oxford). 2006;8(2):114-5. PMID: 18333258.
2.91
Grazi GL, Cescon M, Ravaioli M, Corti B, Pinna AD. Successful liver transplantation from a 95-year-old donor to a patient with MELD score 36 and delayed graft arterialization. Am J Transplant. 2008 Mar;8(3):725-6. PMID: 18294175.
5.66
Ravaioli M, Cescon M, Mikus E, Grazi GL, Ercolani G, Kimura T, Tuci F, Mikus
PM, Bernardi M, Pinna AD. Liver and partial atrium transplantation for chronic
Budd-Chiari syndrome. Liver Transpl. 2007 Dec;13(12):1758-9. PMID: 18044780.
3.75
Cescon M, Grazi GL, Ravaioli M, Cucchetti A, Ercolani G, Pinna AD. Modified outflow reconstruction with a venous patch in domino liver transplantation. Liver Transpl. 2007 Dec;13(12):1756-7. PMID: 18044779.
3.95
Nigri GR, Di Giulio E, Di Nardo R, Pezzoli F, D'Angelo F, Aurello P, Ravaioli M, Ramacciato G. Duodenal perforation and right hydronephrosis due to toothpick ingestion. J Emerg Med. 2008 Jan;34(1):55-7. PMID: 17976746.
1.20
Aurello P, Rossi S, D'Angelo F, Nigri G, Cicchini C, Ciardi A, Coluccia P, Ercolani G, Cescon M, Cucchetti A, Ravaioli M, Del Gaudio M, Ramacciato G. [Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer]. Chir Ital. 2007 Jul-Aug;59(4):435-44. Italian. PMID: 17966762.
0.29
Ramacciato G, Mercantini P, La Torre M, Di Benedetto F, Ercolani G, Ravaioli M, Piccoli M, Melotti G. Is laparoscopic adrenalectomy safe and effective for adrenal masses larger than 7 cm? Surg Endosc. 2008 Feb;22(2):516-21. PMID: 17704864.
3.11
Gramantieri L, Giovannini C, Lanzi A, Chieco P, Ravaioli M, Venturi A, Grazi GL, Bolondi L. Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. Liver Int. 2007 Sep;27(7):997-1007. PMID: 17696940.
4.50
Grazi GL, Vetrone G, Ercolani G, Cescon M, Ravaioli M, Zanello M, Corti B, Pinna AD. Associated benign liver tumors in idiopathic granulomatous hepatitis: A case report. Hepatol Res. 2007 Jul;37(7):568-71. PMID: 17540000.
3.41
Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Liver Transpl. 2007 Jun;13(6):857-66. PMID: 17539006.
3.75
Ravaioli M, Masetti M, Ridolfi L, Capelli M, Grazi GL, Venturoli N, Di Benedetto F, Bianchi FB, Cavrini G, Faenza S, Begliomini B, Pinna AD, Gerunda GE, Ballardini G. Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment. Transplantation. 2007 Apr 15;83(7):919-24. PMID: 17460563.
3.96
Vivarelli M, La Barba G, Cucchetti A, Lauro A, Del Gaudio M, Ravaioli M, Grazi GL, Pinna AD. Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? Liver Transpl. 2007 May;13(5):651-4. PMID: 17457885.
3.75
Ramacciato G, Mercantini P, Nigri GR, Ravaioli M, Cautero N, Di Benedetto F, Masetti M, Grazi GL, Ziparo V, Ercolani G, Pinna AD. Univariate and multivariate analysis of prognostic factors in the surgical treatment of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology. 2006 Nov-Dec;53(72):898-903. PMID: 17153449.
0.79
Cucchetti A, Ercolani G, Cescon M, Ravaioli M, Zanello M, Del Gaudio M, Lauro A, Vivarelli M, Grazi GL, Pinna AD. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg. 2006 Nov;203(5):670-6. PMID: 17084328.
4.76
Ravaioli M, Grazi GL, Ercolani G, Cescon M, Pinna AD, Ballardini G. The future challenge in the MELD era: how to match extended-use donors and sick recipients. Transplantation. 2006 Oct 15;82(7):987-8. PMID: 17038919.
3.96
Grassi A, Quarneti C, Ravaioli M, Bianchini F, Susca M, D'Errico A, Piscaglia F, Tamè MR, Andreone P, Grazi G, Galli S, Zauli D, Pinna AD, Bianchi FB, Ballardini G. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C. Liver Transpl. 2006 Nov;12(11):1673-81. PMID: 17031825.
3.75
Ercolani G, Cucchetti A, Cescon M, Ravaioli M, Grazi GL, Pinna AD. Predictive indices of morbidity and mortality after liver resection. Ann Surg. 2006 Oct;244(4):635-7; author reply 637. PMID: 16998379.
9.20
Ramacciato G, Nigri GR, Aurello P, D'Angelo F, Pezzoli F, Rossi S, Pilozzi E, Ercolani G, Ravaioli M. Giant hepatic adenoma with bone marrow metaplasia not associated with oral contraceptive intake. World J Surg Oncol. 2006 Aug 25;4:58. PMID: 16934137.
1.79
Ramacciato G, Aurello P, D'Angelo F, Pezzoli F, Bellagamba R, Nigri G, Cicchini C, Ravaioli M, Ercolani G, Vetrone G, Del Gaudio M, De Angelis R. [Impact of new lymph node staging on lymphadenectomy and on the prognosis of patients undergoing surgery for gastric cancer]. Chir Ital. 2006 May-Jun;58(3):285-94. Italian. PMID: 16845863.
0.29
Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Cescon M, Varotti G, Ramacciato G, Vetrone G, Zanello M, Pinna AD. Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. Liver Transpl. 2006 Jul;12(7):1104-11. PMID: 16710855.
3.75
Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, Zanello M, Grazi GL, Pinna AD. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 2006 Jun;12(6):966-71. PMID: 16598792.
3.75
Cescon M, Grazi GL, Grassi A, Ravaioli M, Vetrone G, Ercolani G, Varotti G, D'Errico A, Ballardini G, Pinna AD. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transpl. 2006 Apr;12(4):628-35. PMID: 16555338.
3.75
Ravaioli M, Grazi GL, Ercolani G, Cescon M, Del Gaudio M, Zanello M, Ballardini G, Varotti G, Vetrone G, Tuci F, Lauro A, Ramacciato G, Pinna AD. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. Transplantation. 2006 Feb 27;81(4):525-30. PMID: 16495798.
3.96
Ramacciato G, Varotti G, Quintini C, Masetti M, Di Benedetto F, Grazi GL, Ercolani G, Cescon M, Ravaioli M, Lauro A, Pinna A. Impact of biliary complications in right lobe living donor liver transplantation. Transpl Int. 2006 Feb;19(2):122-7. PMID: 16441361.
3.19
Vetrone G, Ercolani G, Grazi GL, Ramacciato G, Ravaioli M, Cescon M, Varotti G, Del Gaudio M, Quintini C, Pinna AD. Surgical therapy for hepatolithiasis: a Western experience. J Am Coll Surg. 2006 Feb;202(2):306-12. PMID: 16427557.
4.76
Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl. 2005 Sep;11(9):1117-26. PMID: 16123960.
3.75
Varotti G, Grazi GL, Vetrone G, Ercolani G, Cescon M, Del Gaudio M, Ravaioli
M, Cavallari A, Pinna A. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant. 2005 Aug;19(4):492-500. PMID: 16008594.
1.51
De Ruvo N, Cucchetti A, Lauro A, Masetti M, Cautero N, Di Benedetto F, Dazzi A, Del Gaudio M, Ravaioli M, Di Francesco F, Molteni G, Ramacciato G, Risaliti A, Pinna AD. Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation. Transplantation. 2005 Jul 15;80(1):8-12. PMID: 16003226.
3.96
Cucchetti A, Vivarelli M, Piscaglia F, Nardo B, Montalti R, Grazi GL, Ravaioli M, La Barba G, Cavallari A, Bolondi L, Pinna AD. Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. J Hepatol. 2005 Aug;43(2):310-6. PMID: 15970351.
15.04
Ercolani G, Grazi GL, Ravaioli M, Ramacciato G, Cescon M, Varotti G, Del Gaudio M, Vetrone G, Pinna AD. The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol. 2005 Jun;12(6):459-66. PMID: 15886903.
3.85
Del Gaudio M, Grazi GL, Ercolani G, Ravaioli M, Varotti G, Cescon M, Vetrone G, Ramacciato G, Pinna AD. Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. Clin Transplant. 2005 Jun;19(3):399-405. PMID: 15877805.
1.51
Cescon M, Grazi GL, Varotti G, Ravaioli M, Ercolani G, Gardini A, Cavallari A. Venous outflow reconstructions with the piggyback technique in liver transplantation: a single-center experience of 431 cases. Transpl Int. 2005 Mar;18(3):318-25. PMID: 15730493.
3.19
Ravaioli M, Grazi GL, Ercolani G, Fiorentino M, Cescon M, Golfieri R, Trevisani F, Grigioni WF, Bolondi L, Pinna AD. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation. 2004 Dec 27;78(12):1780-6. PMID: 15614151.
3.96
Grassi A, Susca M, Ravaioli M, Grazi GL, D'Errico A, Bontadini A, Zauli D, Pinna A, Bianchi FB, Ballardini G. Detection of recipient's cells in liver graft using antibodies to mismatched HLA class I antigens. Liver Transpl. 2004Nov;10(11):1406-14. PMID: 15497144.
3.75
Ravaioli M, Ercolani G, Cescon M, Vetrone G, Voci C, Grigioni WF, D'Errico A, Ballardini G, Cavallari A, Grazi GL. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl. 2004 Sep;10(9):1195-202. PMID: 15350014.
3.75
Gardini A, Ercolani G, Riccobon A, Ravaioli M, Ridolfi L, Flamini E, Ridolfi R, Grazi GL, Cavallari A, Amadori D. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. J Surg Oncol. 2004 Jul 15;87(1):46-52. PMID: 15221919.
2.88
Ercolani G, Principe A, Ravaioli M, Cescon M, Grazi GL. Long-term survival after two-stage hepatectomy for colorectal metastases: a case report. Hepatogastroenterology. 2004 Mar-Apr;51(56):592-4. PMID: 15086211.
0.79
Del Gaudio M, Grazi GL, Principe A, Ravaioli M, Ercolani G, Cescon M, Varotti G, Gardini A, Cavallari A. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis. Hepatogastroenterology. 2004 Mar-Apr;51(56):510-4. PMID: 15086193.
0.79
Fiorentino M, Altimari A, Ravaioli M, Gruppioni E, Gabusi E, Corti B, Vivarelli M, Bringuier PP, Scoazec JY, Grigioni WF, D'Errico-Grigioni A. Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. Clin Cancer Res. 2004 Mar 1;10(5):1789-95. PMID: 15014033.
10.19
Ercolani G, Grazi GL, Ravaioli M, Grigioni WF, Cescon M, Gardini A, Del Gaudio M, Cavallari A. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg. 2004 Feb;239(2):202-9. PMID: 14745328.
9.20
Grazi GL, Cescon M, Ravaioli M, Ercolani G, Gardini A, Del Gaudio M, Vetrone G, Cavallari A. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:119-29. PMID: 12786623.
7.35
Cescon M, Grazi GL, Ercolani G, Nardo B, Ravaioli M, Gardini A, Cavallari A. Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable? Liver Transpl. 2003 Nov;9(11):1174-80. PMID: 14586878.
3.75
Ravaioli M, Grazi GL, Principe A, Ercolani G, Cescon M, Gardini A, Varotti G, Del Gaudio M, Cavallari A. Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis. Hepatogastroenterology. 2003 Sep-Oct;50(53):1552-5. PMID: 14571784.
0.79
Grazi GL, Cescon M, Salvi F, Ercolani G, Ravaioli M, Arpesella G, Magelli C, Grigioni F, Cavallari A. Combined heart and liver transplantation for familial amyloidotic neuropathy: considerations from the hepatic point of view. Liver Transpl. 2003 Sep;9(9):986-92. PMID: 12942463.
3.75
Ravaioli M, Guarino M, Stracciari A, Grazi GL, Pastore Trossello M, Ercolani G, Cavallari A. Speech disorder related to tacrolimus-induced pontine myelinolysis after orthotopic liver transplantation. Transpl Int. 2003 Aug;16(8):507-9. PMID: 12819864.
3.19
Grazi GL, Ercolani G, Varotti G, Cescon M, Ravaioli M, Cavallari A. Right-side approach to the left caudate lobe in the piggy-back technique of liver transplantation. A further step in maximizing preservation of the retrohepatic inferior vena cava. Transpl Int. 2003 May;16(5):361-3. PMID: 12759728.
3.19
Cescon M, Grazi GL, Del Gaudio M, Ercolani G, Ravaioli M, Nardo B, Cavallari A. Outcome of right hepatectomies in patients older than 70 years. Arch Surg. 2003 May;138(5):547-52. PMID: 12742961.
8.50
Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, Cescon M, Varotti G, Cetta F, Cavallari A. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg. 2003 Apr;237(4):536-43. PMID: 12677151.
9.20
Ercolani G, Grazi GL, Ravaioli M, Cescon M, Gardini A, Varotti G, Del Gaudio M, Nardo B, Cavallari A. Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg. 2002 Oct;137(10):1187-92. PMID: 12361432.
8.50
Stirpe F, Ravaioli M, Battelli MG, Musiani S, Grazi GL. Xanthine oxidoreductase activity in human liver disease. Am J Gastroenterol. 2002 Aug;97(8):2079-85. PMID: 12190180.
10.38
Barozzi C, Ravaioli M, D'Errico A, Grazi GL, Poggioli G, Cavrini G, Mazziotti A, Grigioni WF. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer. 2002 Feb 1;94(3):647-57. PMID: 11857296.
6.53
Cescon M, Mazziotti A, Grazi GL, Ravaioli M, Pierangeli F, Ercolani G, Cavallari A. Evaluation of the use of graft livers procured from old donors (70 to 87 years) for hepatic transplantation. Transplant Proc. 2001 Feb-Mar;33(1-2):934-5. PMID: 11267135.
0.80
Grazi GL, Cescon M, Ravaioli M, Ercolani G, Pierangeli F, D'Errico A, Ridolfi L, Cavallari A, Mazziotti A. A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant. 2001 May;1(1):61-8. PMID: 12095041.
5.66
